Morgan’s Monopoly Digest – August 2022

Anti-Monopoly Policies & EnforcementCompetition Policy Digest

August 10, 2022 — Economic Liberties' Director of Policy & Advocacy Morgan Harper launched a monthly newsletter to catalogue the latest with the “antitrust agencies,” the Federal Trade Commission (FTC) and the Department of Justice (DOJ), Antitrust Division, as well as cover the work of other federal agencies that regulate competition policy.

USA Today: Don’t let the airlines fool you. Regulate their cancellations and high fares.

Anti-Monopoly Policies & Enforcement

July 21, 2022 — In USA Today, Economic Liberties’ Senior Fellow for Aviation & Travel Bill McGee lays out the causes of the current airline and travel crisis, highlighting Secretary Buttigieg’s inadequate response and arguing for rolling back federal preemption, which currently prevents state attorneys general among others from holding the airlines accountable.

The Pharmacy Benefit Mafia: The Secret Health Care Monopolies Jacking Up Drug Prices and Abusing Patients and Pharmacists

Anti-Monopoly Policies & EnforcementHealthcare

June 22, 2022 — Designed to catalogue the ways PBMs wield their power to exploit patients, pharmacists, doctors and our government, "The Pharmacy Benefit Mafia" details PBMs’ abusive business practices, their history of skirting regulation, and how the FTC’s recent efforts can put power back into the hands of patients and pharmacists.

The Guardian: The US baby formula shortage isn’t bad luck. It was completely preventable

Anti-Monopoly Policies & Enforcement

June 13, 2022 — In The Guardian, Economic Liberties’ Research Director Matt Stoller explains how shortages of vital, life-preserving goods are routine in America – and they’re the product of bad policy.

ProMarket: Mergers and Smoking Guns

Anti-Monopoly Policies & Enforcement

May 13, 2022 — In 1980, Richard Posner and George Stigler drafted a memo to help the Reagan admin “throttle back” antitrust enforcement. As Economic Liberties’ Research Manager & Editor Erik Peinert details for ProMarket, “it gets to the heart of current debates about the direction of antitrust.”